RapidAI Stock

www.rapidai.com/Healthcare / Healthcare softwareFounded: 2011Funding to Date: $93.84MM

RapidAI is a diagnostic technology company that uses neuroimaging analysis to make accurate diagnostic decisions for aneurysm and stroke patients. With clinical trial solutions, RapidAI has a mission of redefining traditional neurologic care and uses software to advance medical technology. The company also features analytic insights to improve operational care. RapidAI was founded by Gregory Albers and Karim Karti in 2011 and is headquartered in San Francisco, CA.

Register To Buy and Sell Shares

For more details on financing and valuation for RapidAI, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access RapidAI’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like RapidAI.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

RapidAI investors also invested in these private companies

Vista Credit Partners
Cullom Capital
Lennertz & Co.
Listwin Ventures


Management Team

Gregory Albers MD
Co-Founder & Scientific Lead
Amit Phadnis
Chief Innovation and Technology Officer
Roland Bammer Ph.D
Co-Founder & Technical Lead
Karim Karti
Chief Executive Officer

Board Members

Erol Dervis
Lennertz & Co.

Frequently Asked Questions About RapidAI’s Stock

Can you buy RapidAI’s stock?
RapidAI is not publicly traded on NYSE or NASDAQ in the U.S. To buy RapidAI’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell RapidAI’s stock?
Yes, you can sell stock of a private company like RapidAI. Forge can help you sell your RapidAI stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is RapidAI’s stock price?
RapidAI is a privately held company and therefore does not have a public stock price. However, you may access RapidAI’s private market stock price with Forge Data.
What is RapidAI’s stock ticker symbol?
RapidAI does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

RapidAI racks up $75M for software to spot strokes, aneurysms
True to its name, RapidAI is working quickly to build out its slate of artificial-intelligence-powered software tools designed to spot signs of stroke, aneurysm and other neurological conditions in brain CT scans. To help with that acceleration, the Silicon Valley-based startup has raised $75 million in a recent funding round.
Updated on: Apr 15, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.